TABLE 2.
β-Lactam(s)a | β-Lactam MIC (μg/ml) for:
|
||
---|---|---|---|
N. farcinica VIC | E. coli JM109(pFAR-1) | E. coli JM109 | |
Benzylpenicillin | 512 | NDb | ND |
Benzylpenicillin + CLA | 8 | ND | ND |
Benzylpenicillin + TZB | 128 | ND | ND |
Benzylpenicillin + SUL | 256 | ND | ND |
Amoxicillin | 64 | 256 | 2 |
Amoxicillin + CLA | 1 | 8 | 2 |
Amoxicillin + TZB | 64 | 256 | 2 |
Amoxicillin + SUL | 64 | 128 | 2 |
Ticarcillin | 256 | 512 | 2 |
Ticarcillin + CLA | 8 | 16 | 1 |
Ticarcillin + TZB | 128 | 512 | 1 |
Ticarcillin + SUL | 256 | 256 | 2 |
Piperacillin | 512 | 32 | 1 |
Piperacillin + CLA | 32 | 2 | 0.5 |
Piperacillin + TZB | 256 | 32 | 0.5 |
Piperacillin + SUL | 256 | 16 | 0.5 |
Cephalothin | 128 | 8 | 4 |
Cephalothin + CLA | 64 | 8 | 2 |
Cephalothin + TZB | 128 | 4 | 2 |
Cephalothin + SUL | 128 | 4 | 2 |
Cefoxitin | 128 | 4 | 4 |
Cefoxitin + CLA | 64 | 4 | 4 |
Cefoxitin + TZB | 64 | 4 | 4 |
Cefoxitin + SUL | 64 | 4 | 4 |
Ceftazidime | >512 | 0.25 | 0.25 |
Ceftazidime + CLA | >512 | 0.25 | 0.25 |
Ceftazidime + TZB | >512 | 0.25 | 0.25 |
Ceftazidime + SUL | >512 | 0.25 | 0.25 |
Cefotaxime | 256 | 0.06 | 0.06 |
Cefotaxime + CLA | 128 | 0.06 | 0.06 |
Cefotaxime + TZB | 128 | 0.06 | 0.06 |
Cefotaxime + SUL | 256 | 0.06 | 0.06 |
Aztreonam | >512 | 1 | 0.12 |
Aztreonam + CLA | 512 | 0.12 | 0.06 |
Aztreonam + TZB | 512 | 1 | 0.06 |
Aztreonam + SUL | 512 | 0.5 | 0.06 |
Cefepime | 128 | 0.12 | 0.06 |
Cefepime + CLA | 64 | <0.06 | 0.06 |
Cefepime + TZB | 128 | <0.06 | 0.06 |
Cefepime + SUL | 128 | <0.06 | 0.06 |
Imipenem | 1 | 0.06 | 0.06 |
Imipenem + CLA | 1 | 0.06 | 0.06 |
Imipenem + TZB | 1 | 0.06 | 0.06 |
Imipenem + SUL | 1 | 0.06 | 0.06 |
Meropenem | 0.25 | <0.06 | <0.06 |
Meropenem + CLA | 0.25 | <0.06 | <0.06 |
Meropenem + TZB | 0.25 | <0.06 | <0.06 |
Meropenem + SUL | 0.25 | <0.06 | <0.06 |
CLA, clavulanic acid at a fixed concentration of 2 μg/ml; TZB, tazobactam at a fixed concentration of 4 μg/ml; SUL, sulbactam at a fixed concentration of 8 μg/ml.
ND, not determined.